Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents (Q34288915)

1 August 2017

1 reference

title

Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents (English)

1 reference

1 August 2017

Newton DL

1

1 reference

1 August 2017

Hansen HJ

2

1 reference

1 August 2017

Liu H

3

1 reference

1 August 2017

Ruby D

4

1 reference

1 August 2017

Iordanov MS

5

1 reference

1 August 2017

Magun BE

6

1 reference

1 August 2017

Goldenberg DM

7

1 reference

1 August 2017

Rybak SM

8

1 reference

1 August 2017

publication date

1 July 2001

1 reference

Critical Reviews in Oncology Hematology

1 August 2017

published in

1 reference

1 August 2017

volume

39

1 reference

1 August 2017

issue

1-2

1 reference

1 August 2017

page(s)

79-86

1 reference

The epitope specificity and tissue reactivity of four murine monoclonal anti-CD22 antibodies

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Epitope specificity of the anti-(B cell lymphoma) monoclonal antibody, LL2.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Immunotoxins: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Therapeutic potential of anti-HIV immunotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Action of Ribonuclease on Two Solid Tumours in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Action of Ribonuclease on Certain Ascites Tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Striking increase of survival of mice bearing M109 Madison carcinoma treated with a novel protein from amphibian embryos

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Characterization of the mechanism of cellular and cell free protein synthesis inhibition by an anti-tumor ribonuclease.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Full antitumor action of recombinant seminal ribonuclease depends on the removal of its N-terminal methionine

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Refined 1.7 A X-ray crystallographic structure of P-30 protein, an amphibian ribonuclease with anti-tumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Expression and characterization of a cytotoxic human-frog chimeric ribonuclease: potential for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

The Rana catesbeiana rcr gene encoding a cytotoxic ribonuclease. Tissue distribution, cloning, purification, cytotoxicity, and active residues for RNase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Effective expression and purification of recombinant onconase, an antitumor protein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Single amino acid substitutions at the N-terminus of a recombinant cytotoxic ribonuclease markedly influence biochemical and biological properties

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

A gender-specific mRNA encoding a cytotoxic ribonuclease contains a 3' UTR of unusual length and structure

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Patterns of amino acids near signal-sequence cleavage sites

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

The biology of E colicins: paradigms and paradoxes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Epidermal growth factor receptor-dependent cytotoxic effect by an EGF-ribonuclease conjugate on human cancer cell lines--a trial for less immunogenic chimeric toxin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Epidermal growth factor receptor-dependent cytotoxicity for human squamous carcinoma cell lines of a conjugate composed of human EGF and RNase 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Angiogenin single-chain immunofusions: influence of peptide linkers and spacers between fusion protein domains.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Humanization of immunotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Cloning and cytotoxicity of a human pancreatic RNase immunofusion

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Human pancreatic RNase1-human epidermal growth factor fusion: an entirely human 'immunotoxin analog' with cytotoxic properties against squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Cloning and cytotoxicity of fusion proteins of EGF and angiogenin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Design, characterization and anti-tumour cytotoxicity of a panel of recombinant, mammalian ribonuclease-based immunotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Inhibition of cell growth by a fused protein of human ribonuclease 1 and human basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Vascular leak syndrome: a side effect of immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Ricin A-chain and ricin A-chain immunotoxins rapidly damage human endothelial cells: implications for vascular leak syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

Disseminated or localized growth of a human B-cell tumor (Daudi) in SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900116-0

7 January 2021

10.1016/S1040-8428(01)00116-0

Identifiers

DOI

1 reference

1 August 2017

1 reference